1INTRODUCTIONHospital readmissions are a significant source of patient morbidity and put a significant drain on health care resources. Studies have shown that readmissions not only expose the patients to nosocomial infections but also are a considerable source of mental stress. Readmissions significantly amplify the cost of health care in the United States, with Medicare sustaining the largest portion of cost (∼58%), followed by private insurances (∼20%) and Medicaid (∼18%). To reduce the financial burden of these readmissions, the Affordable Care Act (ACA) launched the Hospital Readmission Reduction Program (HRRP), providing financial incentives to health care institutions with low 30‐day readmission rates for certain medical conditions and penalizing those with excess readmissions.Cardiovascular implantable electronic devices (CIEDs) are an established therapy for treatment of patients with lethal ventricular arrhythmias, symptomatic brady‐arrhythmias, and for those with advanced congestive heart failure (CHF). The use of these devices has increased substantially in the last two decades, and their use is expected to increase even more in coming years due to evolving guidelines for device‐based therapy for cardiac rhythm abnormalities in the aging U.S. population.Because of its magnitude and impact on the overall cost of health care, there is a need to assess the national
Journal of Cardiovascular Electrophysiology – Wiley
Published: Jan 1, 2018
Keywords: ; ; ; ;
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera